Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
One Medical Completes Acquisition of Iora Health
September 1, 2021 -
PR Newswire
Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline
September 1, 2021 -
PR Newswire
Benchling Names Salesforce Executive Lindsey Irvine as Chief Marketing Officer
September 1, 2021 -
PR Newswire
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
September 1, 2021 -
TechCrunch
Oviva grabs $80M for app-delivered healthy eating programs
September 1, 2021 -
Fierce Healthcare
AppliedVR taps Curebase to run at-home clinical trials testing VR for pain treatment
August 31, 2021 -
Business Wire
Nocion Therapeutics Announces Dosing Underway in Participants with Chronic Cough
August 31, 2021 -
FierceBiotech
Insilico Medicine taps 4B Technologies’ neurological know-how to build AI-designed ALS drugs
August 27, 2021 -
GlobeNewswire
Denali Therapeutics Announces Publication in Cell on New Approach to Treat FTD-GRN
August 26, 2021 -
GlobeNewswire
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
August 26, 2021 -
GlobeNewswire
Ultragenyx Announces Approval of Dojolvi® (triheptanoin) in Brazil for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Adults and Children
August 23, 2021 -
GlobeNewswire
Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106, in Combination Therapy with KEYTRUDA® (pembrolizumab)
August 19, 2021 -
Business Wire
NFlection Therapeutics Announces Orphan Drug Designation of NFX-179 for the Treatment of Cutaneous Neurofibromatosis Type 1
August 18, 2021 -
GlobeNewswire
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
August 18, 2021 -
Forbes
Fertility Startup Carrot Raises $75 Million In A Series C Round
August 17, 2021 -
Business Wire
Xilio Therapeutics Appoints Sara Bonstein to Its Board of Directors
August 17, 2021 -
Endpoints News
As US review of Eli Lilly-partnered PD-1 gets underway, Innovent touts another frontline win in China
August 16, 2021 -
PR Newswire
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use
August 16, 2021 -
PR Newswire
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
August 15, 2021 -
PR Newswire
Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company’s Embrace of the Future of Work
August 11, 2021 -
PR Newswire
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director
August 11, 2021 -
PR Newswire
1upHealth Announces Free Baseline Testing for Health Plans to Determine if their Patient Access FHIR® API is Successfully Connecting as Required by CMS
August 11, 2021 -
Forbes
Beam Therapeutics Is Aiming To Start Human Trials For Its Sickle Cell Treatment
August 10, 2021 -
Business Wire
WellAir Appoints Kari Dixon as Chief Financial Officer
August 10, 2021 -
PR Newswire
MaxCyte Signs Clinical and Commercial License with Sana Biotechnology
August 9, 2021 -
PR Newswire
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
August 9, 2021 -
GlobeNewswire
Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors
August 9, 2021 -
PR Newswire
Innovent Announces the Establishment of the Scientific Advisory Board
August 8, 2021 -
GlobeNewswire
BenchSci Announces Craig Newell as New Chief Architect Officer as it Broadens Biomedical AI Platform
August 6, 2021 -
PR Newswire
EY Announces Nick Culbertson of Protenus as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Winner
August 5, 2021 -
PR Newswire
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI
August 5, 2021 -
PR Newswire
Health Payment Systems, Inc. Names Centivo as a Third-Party Administrator for BHCG Member-Employers
August 4, 2021 -
FierceBiotech
Insilico Medicine’s AI engines continue to churn out new drug candidates, now in kidney fibrosis
August 4, 2021 -
PR Newswire
Buoy Health Publishes White Paper on Post-Pandemic Transformation of U.S. Healthcare Navigation
August 3, 2021 -
PR Newswire
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus
August 2, 2021 -
GlobeNewswire
Cytek Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
Business Wire
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
August 2, 2021 -
PR Newswire
BenchSci Extends Impact on Drug Discovery With Addition of AI-Assisted Animal Model Selection
July 28, 2021 -
Fierce Healthcare
Behavioral health matchmaker SonderMind hits unicorn status with $150M series C
July 28, 2021 -
GlobeNewswire
Cytek Biosciences Announces Closing of Its Initial Public Offering
July 27, 2021 -
PR Newswire
RareStone Inc. Announces Strategic Collaboration with Tencent on a Service Ecosystem Focused on Rare Disease Patients in China
July 27, 2021 -
Business Wire
LTC ACO Selects PatientPing’s Real-Time E-Notification System to Improve Patient Outcomes and Lower Total Cost of Care for Medicare Beneficiaries Across the Healthcare Continuum
July 27, 2021 -
PR Newswire
Embark Veterinary Announces $75M Series B Funding Led by SoftBank Vision Fund 2
July 26, 2021 -
GlobeNewswire
Denali Therapeutics Announces Positive Interim Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with the Lysosomal Storage Disease Hunter Syndrome (MPS II)
July 25, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 25, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences prices upsized IPO at $17 midpoint
July 24, 2021 -
BioPharma Dive
Caribou raises $304M in one of gene editing’s most lucrative IPOs
July 23, 2021 -
Nasdaq
Rare disease biotech Rallybio sets terms for $81 million IPO
July 22, 2021 -
GlobeNewswire
Adagene Announces Clinical Trial Collaboration With Merck to Advance Two Anti-CTLA-4 Monoclonal Antibody Programs (ADG116 and ADG126) in Combination Therapy with KEYTRUDA® (pembrolizumab)
July 22, 2021 -
PR Newswire
RareStone Inc. Announces Submission of New Drug Application (NDA) of Wakix® (pitolisant) for narcolepsy with and without cataplexy in China
July 21, 2021 -
GlobeNewswire
Coherus BioSciences Names Physician-Scientist Ildiko Csiki, M.D., Ph.D., Chair of its Scientific Advisory Board
July 21, 2021 -
GlobeNewswire
Affinia Therapeutics Announces Collaboration with the Institute of Molecular and Clinical Ophthalmology Basel (IOB) To Rationally Design Novel CNS Promoters for Gene Therapy
July 20, 2021 -
PR Newswire
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership
July 20, 2021 -
Business Wire
AtlantiCare Expands Consumer Self-Service with Digital Access Solutions from Kyruus
July 20, 2021 -
Endpoints News
As its next big bet, Sana inks long-term lease for manufacturing site for next-gen cell therapies
July 15, 2021 -
PR Newswire
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
July 15, 2021 -
PR Newswire
Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment
July 14, 2021 -
Business Wire
Devoted Health Announces Maine Office Expansion, Creating at Least 40 New Jobs in Cumberland County
July 14, 2021 -
TechCrunch
Castor, a clinical trial process company, raises $45M to create more human-centered research
July 14, 2021 -
Forbes
Prime Medicine – This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases
July 13, 2021 -
GlobeNewswire
Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Spain
July 13, 2021 -
Business Wire
Stamford Health Chooses PatientPing’s Route Solution to Achieve E-Notifications CoP Compliance Under CMS’s Interoperability and Patient Access Rule
July 13, 2021 -
PR Newswire
Everest Medicines Announces Strategic Collaboration with Medbanks Health Technology to Develop Innovative Healthcare Service Solutions for Patients in China
July 13, 2021 -
Business Wire
Caribou Biosciences Announces Dosing of First Patient in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
July 12, 2021 -
Endpoints News
WHO issues new guidelines for gene editing; Doudna-backed Caribou launches its first allogeneic CAR-T trial
July 12, 2021 -
PR Newswire
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
July 8, 2021 -
PR Newswire
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
July 5, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences files for a $100 million IPO
July 2, 2021 -
Business Wire
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
July 2, 2021 -
GlobeNewswire
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
July 1, 2021 -
MarketWatch
Caribou Biosciences files for IPO to help fund drug studies
July 1, 2021 -
GlobeNewswire
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
July 1, 2021 -
GlobeNewswire
Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases
June 30, 2021 -
GlobeNewswire
Carrot Fertility and RESOLVE Uncover Fertility and Family-Forming Trends in New Fertility at Work Study
June 30, 2021 -
GlobeNewswire
Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
June 30, 2021 -
Business Wire
Turnstone Biologics Appoints Stewart Abbot, Ph.D., as Chief Scientific Officer
June 29, 2021 -
Business Wire
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021 -
PR Newswire
Protenus Announces Nick Culbertson Is an EY Entrepreneur of the Year® 2021 Mid-Atlantic Award Finalist
June 28, 2021 -
PR Newswire
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
June 28, 2021 -
GlobeNewswire
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
June 28, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
FierceBiotech
Boston Scientific shells out a hearty $295M for Farapulse’s electric-field-generating afib treatment
June 24, 2021 -
GlobeNewswire
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
June 23, 2021 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
June 21, 2021 -
GlobeNewswire
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 21, 2021 -
Business Wire
Xilio Therapeutics Announces FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors
June 17, 2021 -
Economic Times
PharmEasy valued at $1.8 billion as B Capital buys stake for $20 million
June 17, 2021 -
MarketWatch
Verve Therapeutics shares soar 68% in trading debut
June 17, 2021 -
Business Wire
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others
June 17, 2021
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.